Clinical Trial Applications (CTAs) - requirements

Clinical Trial Applications (CTAs) - requirements The following section provides the requirements for a CTA involving the use of pharmaceutical, biological, and radiopharmaceutical drugs. The requirements are the same for these drug products with a few exceptions. 2022-06-07 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyclinical trial applicationsCTAsCTA involving pharmaceuticalCTA involving biologicalCTA involving radiopharmaceutical-drugs Clinical Trial Applications (CTAs) - requirementsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/applications.html Clinical Trial Applications (CTAs) - requirementsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/essais-cliniques/demandes.html

The following section provides the requirements for a CTA involving the use of pharmaceutical, biological, and radiopharmaceutical drugs. The requirements are the same for these drug products with a few exceptions.

Data and Resources

Similar records